Elucidating the Epidemiology of Human Salmonellosis: The Value of Systematic Laboratory Characterisation of Isolates by P. McKeown et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Elucidating the Epidemiology of Human 
Salmonellosis: The Value of Systematic 
Laboratory Characterisation of Isolates  
P. McKeown1, P. Garvey1 and M. Cormican2 
1Health Protection Surveillance Centre, Dublin 
2National Salmonella Reference Laboratory, Bacteriology Department 
Galway University Hospital 
Ireland 
1. Introduction 
Infection with non-typhoidal Salmonella enterica (NTS) represents a significant burden of 
gastroenteric illness upon the world’s population. Most enteric Salmonella infection is 
zoonotic, transmitted from healthy vertebrate animals to humans, largely by means of 
contaminated food. The reported incidence of enteric salmonellosis increased rapidly after 
the Second World War in association with progressive industrialisation of the food supply, 
at a time when the incidence of typhoid was declining, consequent upon the extensive 
development of water treatment and waste disposal systems, coupled with the 
pasteurization of milk.1 As a result, infection with NTS displaced typhoid in the developed 
world as the major threat to human health from Salmonella during the 20th century. 
Salmonellae have evolved into a diverse genus of Enterobacteriaceae; some members being 
adapted to specific hosts with others having a broad host range. In addition to their wide 
spectrum of zoonotic hosts, salmonellae vary greatly in age (S. Typhi having emerged more 
recently than S. Typhimurium), in lineage and in clonality. Accordingly, a variety of 
genome-based methods must be used in order to provide appropriate methods for 
characterisation of different variants 
One hundred million cases of salmonellosis are estimated to occur globally each year. 
Estimates of incidence range from 32 cases/100,000 population in high income areas of the 
Asia Pacific region to 3,600/100,000 population in Southeast Asia.2 Annually, this results in 
155,000 deaths worldwide. Mortality rates from salmonellosis are highest in East and 
Southeast Asia and lowest in the developed countries of Europe, North America and 
Oceania.  
About 80% of all salmonellosis cases are estimated to be foodborne (rising to 94% in the 
United States).3 Reported incidence varies widely, not least in developed countries, 
reflecting both real differences in incidence (driven by variations in farming/food 
production practices, the existence of Salmonella Control Programs and food consumption 
patterns), and the effects of variability in surveillance parameters, and health care and 
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diagnostic systems. In Western Europe and in high-income regions of North America, total 
incidence (which includes confirmed NTS cases combined with projections based upon 
population models) is estimated to be 220/100,000 and 495/100,000 respectively.2 
These figures do not, however, paint the full picture. Although there is marked regional 
variation, there has been a steady decrease in the total confirmed notification rates for 
salmonellosis in the European Union over the last six years from 196,000 cases in 2004 to 
108,000 cases in 2009 (or 21.6 cases /100 000 population), representing an average 12% fall 
per year.4 The incidence has remained static in Ireland (at 10 cases/100,000 between 2006 
and 2008) but has fallen in the UK (from 23 to 19/100,000 cases) over the same period. 
Certain countries, however, have seen marked increases in reported incidence between 2006 
and 2008 (from from 31 to 67 cases/100,000 in Denmark and from 16 to 39 cases/100,000 in 
Malta) while others report steep declines in incidence (such as the Czech Republic falling 
from 236 to 103 cases/100,000 and from 64 to 52 cases/100,000 in Germany).5  
In the United States, approximately 40,000 laboratory-confirmed cases of Salmonella infection 
are reported annually to the National Salmonella Surveillance System in the United States, 
giving an annualised incidence rate, in 2006 of 13.3 cases per 100,000 population (CDC, 
2011).6  
Under-ascertainment of enteric salmonellosis is a significant concern. In the UK, the ratio of 
Salmonella isolates reported nationally to cases occurring in the community has been 
estimated as being 4.7, i.e. 3.7 undetected community cases for each laboratory confirmed 
case included in national statistics.7  
Salmonellosis underascertainment has been estimated in a range of European countries 
using an intriguing method by Swedish researchers.8 Investigators calculated the incidence 
of salmonellosis acquired overseas among returning Swedish travellers on a country-specific 
basis and compared this derived incidence against nationally reported incidence in the 
country in which the case had acquired their infection. As a result, they estimated that there 
was significant variation in the ratio of underdetection by the national reporting systems of 
the countries involved, ranging from less than one in the case of Finnish and Icelandic 
systems (i.e. these systems were more sensitive at detecting salmonellosis than the Swedish 
travel-based system) to 98 and 270 in the case of Greek and Bulgarian systems, suggesting 
that these systems were considerably less sensitive at detecting salmonellosis than the 
Swedish travel-based system. Interestingly, the underdetection index for Ireland was 4.3 - 
precisely the same as that found for the UK.8 The authors note that the behaviours and risks 
of Swedish travellers may not be fully representative for those of the native population; 
nevertheless, it provides an interesting comparative snapshot of potential Salmonella 
underascertainment in Europe. 
The Centers for Disease Control and Prevention (CDC) has recently estimated that the true 
annual incidence of salmonellosis in the US to be 1,027,561 non travel-associated domestic 
cases,3 highlighting the perennial issue of infectious intestinal disease underascertainment. 
Using CDC’s estimates, it can be calculated that for every laboratory confirmed case of 
domestically acquired salmonellosis, there are approximately 25 clinical cases that are not 
laboratory confirmed.  
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Salmonellae are effective outbreak organisms and extensive outbreaks of salmonella occur 
frequently, ranging in size from a couple of cases, to tens of thousands of cases. A significant 
number of these outbreaks are international in distribution and have involved a wide range 
of food products including chocolate,9,10,11 imported eggs,12 infant formula,13 fresh basil,14 
raw milk cheese,15 pork,16 rucola lettuce,17 sprouts,18 pre-cooked meat products,19 lasagne,20 
pet products,21 sesame seeds,22 raw almonds,23 peanuts,24 peanut butter,25 and ready-to-eat 
vegetables.26 In addition, in 2008, the European Food Safety Authority reported 490 
confirmed foodborne outbreaks of salmonellosis resulting in 7,724 cases, 1,363 
hospitalisations and 118 deaths.27  
In considering the relative and absolute burden of human salmonellosis based on data from 
the developed world, it is perhaps striking that NTS infection remains a potent public health 
and clinical challenge, although the majority of developed nations have both well-developed 
surveillance systems to detect human salmonellosis (and the outbreaks that result), and 
farm-based and food hygiene surveillance systems specifically designed to control food-
borne NTS infection. There is however, some comfort in the static or falling incidence of 
salmonellosis in many developed countries.  
A range of emerging factors facilitate the rapid distribution of all foodborne microbes, 
including Salmonella: globalization of the food supply, an aging and highly mobile 
population able to distribute an increasingly diversified intestinal flora more widely, a 
growing proportion of the population at special risk due to immunosuppressive diseases 
such as cancer, or consuming pharmaceutical agents that inhibit either the immune system 
(such as cytotoxic agents) or protective gastric acid secretion (such as proton pump 
inhibitors), changing dietary preferences for raw or lightly cooked food, intensification in 
farming practice, environmental encroachment with greater exposure to novel pathogens, 
climate change and international travel and trade between countries.28  
This importance of increased movement of populations and food is partly reflected in the 
growing proportion of NTS infection attributed either to international travel or to the 
consumption of imported food. Up to half of Irish Salmonella infections are reported as being 
acquired outside Ireland.29 More than 60% of cases of human salmonellosis in Denmark in 
2007 were associated with consumption of imported meat or with international travel.30 The 
Smittskyddsinstitutet, the Swedish government agency with responsibility to monitor the 
epidemiology of communicable diseases, estimates that more that 74% of reported NTS 
infections identified in Sweden are acquired on trips outside that country.31  
The incidence of salmonellosis increased markedly during the 1970s and 1980s. Between 
1976 and 1986, reported infections due to S. Enteritidis (a commensal primarily of poultry, 
particularly chickens) increased more than six-fold in the north-eastern United States,32 
while the incidence of infections due to S. Typhimurium remained static.33 This led 
investigators to wonder if they were witnessing the onset of a novel pandemic.34 A number 
of theories as to the underlying explanation of this increase were considered, including 
clonal expansion of a single, more virulent variant of S. Enteritidis. It was concluded, 
however, that this upsurge was most likely triggered by S. Enteritidis occupying the 
ecological niche left vacant by the established avian Salmonella pathogens, S. Pullorum and 
S. Gallinarum, when those subtypes had been largely eliminated from poultry flocks,34 with 
transmission of human disease being amplified by the progressive intensification of poultry 
farming. 
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2. Identification and linking of cases 
In Ireland, as is common in most other developed countries, the appearance of a clinical 
case of salmonellosis will prompt a number of public health and microbiological 
responses. The management of the individual patient may not require either detailed 
characterisation or antimicrobial susceptibility testing since Salmonella gastroenteritis is 
generally self-limiting. From a public health perspective however, detailed 
characterisation of the isolate may help to determine the extent of linkages, and potential 
sources. Preliminary interviewing of the case seeks to determine if there is 
epidemiological evidence of linkage (to other cases or a possible source) and to determine 
if the case is in a high risk category (in this case, high risk means that they are at increased 
risk of spread of the Salmonella strain; for example, if the case were a food handler and 
confirmed as having salmonellosis s/he would pose a risk of onward transmission). If 
there is laboratory evidence of linkage, each potentially linked case is administered an 
extensive national Salmonella Trawling Questionnaire, designed to question the case in 
close detail to determine if there are exposures common to other, similar cases.35  
It is the knitting together of in-depth clinical public health interviews and definitive 
characterisation of isolates from clinical (and frequently food and animal) specimens, that 
facilitate the identification of common sources of infection, therefore close collaboration 
between public health microbiologists and epidemiologists is essential to effective 
prevention and control.  
2.1 Microbiological identification 
Almost all human cases of NTS infection are associated with a single species; Salmonella 
enterica. However, the highly developed system of sub-classification within the species is 
valuable in linking isolates from different human and non-human sources. 
Confirmation of the diagnosis of human salmonellosis and further characterisation of the 
isolate entails, initially, the bacteriological isolation of the organism from a clinical 
specimen. Clinical samples are typically stool specimens but blood, urine, spinal fluid, joint 
fluid, pus and tissues may be examined. The isolation of Salmonella from faeces requires the 
use of media that allows for the preferential growth of Salmonella from among the complex 
mixture of bacteria that comprise the normal gastrointestinal flora. This is achieved by direct 
culture on selective agar media such as Xylose-Lysine-Desoxycholate agar (XLD) or 
chromogenic agars. To enhance detection of low numbers of Salmonella, stool samples are 
also, generally inoculated into a selective enrichment broth (often Selenite F broth), which is 
plated to selective media after overnight incubation. This two-step process means that, 
although a preliminary indication that a culture is negative on primary plating is typically 
available at 24 hours, a definitive “Not Detected” report is typically not available for 48 
hours. Specimens from normally sterile body sites are typically cultured on non-selective 
agar media (for example blood agar) or broth because there is no requirement to suppress 
competing normal flora. Urine samples are a special case because many clinical laboratories 
do not characterise all significant urine isolates beyond the level of Enterobacteriaceae 
(coliforms). As a result, Salmonella urinary tract infections may go unrecognised. 
It is important that the limitations of the methods used for detection are understood by 
practitioners. The reliability of the result is critically dependent upon the quality 
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management systems in place in the clinical laboratory and, ideally, such laboratories 
should be accredited to the ISO-15189 standard. Even with rigorous control of quality, 
microbiologists should report samples as “Salmonella not detected” (or words of similar 
meaning), avoiding such terms as “Salmonella negative” or “Salmonella absent”. For 
epidemiologists and food safety agencies it is important to understand that even if a 
laboratory uses the term “negative” or “absent” in informal communication, failure to detect 
Salmonella on culture does not entirely exclude the possibility of infection. 
Provisional positive results may be available within 24 hours (from the primary plate) or 
within 48 hours if cultured only from subculture of enrichment broth. Definitive 
confirmation of the isolate and antimicrobial susceptibility testing may require an 
additional working day although a provisional positive report from a laboratory with 
skilled scientists and effective quality systems generally has a very high degree of 
reliability. Confirmation of a suspect colony as being due to Salmonella may be achieved 
by biochemical and serological characterisation or by molecular methods (the latter may 
allow for more rapid confirmation). 
The extent to which clinical laboratories characterise isolates in their own laboratory 
before submission to a reference laboratory, and the frequency with which isolates are 
submitted to reference laboratories, may depend on experience, skills sets, resources and 
funding/reimbursement systems, and ease of access to reference laboratory services. 
Although antimicrobial agents are not required in most patients with Salmonella 
gastroenteritis, this can represent useful preliminary characterisation and is essential to 
guide therapy in those with invasive disease. Antimicrobial susceptibility testing should 
be performed by standardized methods [European Committee on Antimicrobial 
Susceptibility Testing EUCAST), or Clinical Laboratory Standards Institute (CLSI) I or 
International Standards Organization (ISO 20776-1) or by commercial systems validated 
against these standards. Measurements (diameter of zone of inhibition or minimum 
inhibitory concentration; MIC) should be interpreted with reference to EUCAST or CLSI 
interpretive criteria. The use of non-standardised methods for performance or 
interpretation does not form a sound basis for clinical or public health decision-making. 
The use of national standards may provide effective clinical guidance but may limit 
comparability of data with other countries.  
Antimicrobial resistance patterns can provide useful supplementary information about the 
degree of relatedness of members within a particular serotype. Phage typing of serotypes 
such as S. Typhimurium, S. Enteritidis and S. Agona has been used extensively for 
epidemiological purposes. Phage typing is a rapid and discriminatory phenotypic method. 
Interpretation is somewhat subjective; standardization is difficult and phages are not 
generally available from commercial sources.36 However, external quality assessment 
programmes in Europe have confirmed, with a common stock of phage (provided through 
HPA Colindale) coupled with, common methods and training, that national reference 
laboratories can produce comparable phage-typing results for S. Enteritidis and S. 
Typhimurium. In the past, plasmid profiling was used extensively in identifying outbreak 
strains and may still be useful in certain settings. 
Further typing and subtyping by genome-based methods including pulsed field gel 
electrophoresis (PFGE),37 multiple locus variable number tandem repeat (VNTR) analysis 
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(MLVA), multilocus sequence typing (MLST) can add value, however the discriminatory 
power of each molecular method may vary based on the serotype under consideration. In 
the not-too-distant future, single nucleotide polymorphisms (SNPs) and indeed whole 
genome sequencing may be employed to aid in investigating certain outbreaks.38  
2.2 Case linkage 
Linking of cases of salmonellosis (a necessary first step in the identification of outbreaks) 
has, by convention, been undertaken using the traditional epidemiological process of 
describing cases in terms of time, place and person whilst looking for potential linkages 
between cases that might give a clue as to a possible common source for infection.39,40 At an 
early stage, this epidemiological information should be combined with information on 
characterisation of the isolates, as a first step in determining which cases should be included 
(and excluded) as being considered part of a particular cluster or outbreak. Serotype and 
antimicrobial-resistance patterns are generally available at an early stage and may provide 
pointers that isolates might belong to a homogenous group supporting the possibility of a 
common source.  
In countries with smaller populations and/or low reported incidence of infection, the 
appearance of a cluster of isolates of an unusual serotype may be readily detected and 
prompt an investigative response. Countries with larger populations and higher incidence 
may have greater difficulty in identifying a cluster among the background levels and may 
have a higher threshold for response. Advanced systems of triggering exist in some 
countries, and are based on mathematical models to produce an automated alert once an 
expected threshold is exceeded.  
Serotyping and antimicrobial-resistance patterns are of limited value however, in relation to 
serotypes that are very common and widely distributed. In Ireland, in 2008, the five 
commonest Salmonella serotypes (S. Typhimurium, S. Enteritidis, S. Agona, S. Virchow and 
S. Java) accounted for 70% of all isolates (see Figure 1).41 Isolation of such a common 
serotype from two sources (i.e. from two cases or from a case and a food item) may well be a 
chance finding and does not represent persuasive evidence of an epidemiological link. 
Furthermore, isolates of S. Enteritidis are often susceptible to all or most antimicrobial 
agents tested routinely so that most reference laboratories receive a large number of fully 
susceptible S. Enteritidis isolates.. However, thisdegree of identification will not be adequate 
to support public health decision making regarding the degree of relatedness of strains and 
hence the extent of linking that might exist between isolates. It is in this situation that the 
molecular typing methods briefly outlined above add most value. 
There are a number of key principles that must be considered in interpreting laboratory 
data. First, the extent of characterisation performed should be appropriate to address the 
epidemiological and public health issues of concern. Serotyping may be sufficient in some 
cases (especially for rare serotypes) but may be quite inadequate in others. Second, data 
generated by laboratory typing must always be interpreted in the context of: (1) the current 
epidemiological situation, (2) decades of accumulated published experience about routes of 
transmission and (3) an understanding of limitations of the methods used. It is rarely, if 
ever, appropriate to make a determination that isolates are linked or unlinked based solely 
on laboratory typing data. It is important to remember that regardless of the sophistication 
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of the typing methods used, the best that can be achieved is the demonstration of evidence 
of a link between isolates. It is not possible, based on typing methods alone, to determine the 
pathway of transmission (and hence to establish causality), that is to say typing does not 
allow one to determine if the person was infected from the food or if the infected person 
contaminated the food.  
Epidemiologists should be aware of the potential for pseudo-infection and pseudo-
outbreaks related to laboratory cross-contamination of samples. This can be a particular 
issue when a laboratory external quality assessment/proficiency programme has recently 
included a Salmonella isolate in a round of testing. It may be helpful to clarify if the isolate 
was detected on primary agar plate culture, or only following enrichment. In our experience, 
growth of multiple colonies of Salmonella on the primary agar plate is unlikely to be due to 
laboratory cross contamination. However, when there is no growth on the primary agar plate 
but Salmonella is isolated from the Selenite F broth, it is important to consider the possibility of 
cross contamination, in particular if the laboratory has cultured a similar isolate from a clinical 
sample or external quality assessment sample in the previous few days. 
3. Irish data on Salmonella isolates 
Data from Irish national sources give a clear illustration of the degree of variability among 
and within Salmonella serotypes. In Ireland, all Salmonella isolates received at the National 
Salmonella, Shigella and Listeria Reference Laboratory (NSSLRL) at Galway (this includes all 
human clinical, and a number of veterinary and environmental isolates) are serotyped, 
susceptibility to a suite of antimicrobial agents is assessed and all isolates of S. 
Typhimurium and S. Enteritis are differentiated by phage typing. Since 2009, MLVA has 
also been applied routinely to S. Typhimurium isolates providing an additional level of 
discrimination. Additional molecular methods such PFGE are applied selectively during 
cluster/outbreak investigations.  
In all, about 175 different Salmonella serotypes were reported to the NSSLRL between 2000 
and 2010 among Irish clinical isolates. However, the current epidemiology of Salmonella in 
Ireland is dominated by two serotypes, S. Enteritidis and S. Typhimurium (including 
monophasic Typhimurium). These two serotypes accounted for 20% and 38% respectively, 
of human clinical isolates identified in Ireland in 2010, while other serotypes made up the 
remaining 42% of isolates (Figure 1). This represents a change in the relative importance of 
these serotypes since earlier in the decade when S. Enteritidis was consistently the most 
common serotype among Irish clinical isolates.  
Within S. Typhimurium, approximately 90 definitive types have been detected since 2000, 
the 10 most common of which are depicted in Table 1. Overall, DT104 and DT104b have 
been the most common phage types detected. Antimicrobial susceptibility patterns and 
molecular typing (MLVA and PFGE) indicate significant diversity within these phage types. 
Within S. Enteritidis, although PT4 and PT1 have been the most common phage types since 
2000, the number and proportion of both have declined markedly in recent years; in 2010, 
PT14b was the most common type (Table 2). MLVA provides increased discrimination 
within common S. Enteritidis phage types; however, unlike S. Typhimurium, there is not at 
present a clear consensus on a standardized approach to MLVA for this serotype.  
 




[Data source: NSSLRL, Unpublished data] 
Fig. 1. Annual number clinical Salmonella isolates by serotype, Ireland 2000-2010 – [Top ten 
individually represented with all others combined]  
Phage type 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Total (%) 
DT104 194 39 25 22 48 37 24 21 28 24 26 488 (33%) 
DT104b 23 48 49 67 23 13 29 14 27 14 14 321 (21%) 
DT193 11 11 16 4 2 5 11 13 18 27 18 136 (9%) 
U302 8 6 9 8 2 1 7 4 9 3 1 58 (4%) 
Untypable 1 2 0 1 0 7 0 9 7 10 15 52 (3%) 
DT120 1 6 0 0 3 0 1 19 6 6 6 48 (3%) 
DT8 1 1 1 5 28 36 (2%) 
DT12 4 1 6 8 1 3 2 4 29 (2%) 
U311 0 3 3 3 1 0 0 0 0 6 6 22 (1%) 
Other 25 32 23 22 44 19 27 31 40 23 18 304 (20%) 
Total 268 148 131 135 125 85 99 114 139 118 132 
1494 
(100%) 
[Data source: NSSLRL, Unpublished data] 
Table 1. Annual Number S Typhimurium by Definitive Type, Ireland 2000-2010 [Top nine 
individually represented with all others combined] 
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Total 
PT4 162 86 36 58 43 19 33 70 22 7 9 545 (31%) 
PT1 26 74 51 53 48 44 29 13 23 9 14 384 (22%) 
PT21 5 10 5 21 18 12 26 13 22 11 6 149 (8%) 
PT14b 8 6 8 7 11 22 19 17 11 20 17 146 (8%) 
PT8 4 7 12 10 10 20 17 35 14 13 4 146 (8%) 
PT6 3 3 16 13 10 3 4 12 8 4 2 78 (4%) 
PT6a 8 12 9 11 11 3 1 2 1 4 1 63 (4%) 
PT13a  6 3 5 1 1 1 1 2 2 1 23 (1%) 
Untypable 2 1 2 1  2 2 3 1 1 5 20 (1%) 
Other 16 35 20 26 21 19 25 12 18 16 11 219 (12%) 
Total 234 240 162 205 173 145 157 178 122 87 70 
1773 
(100%) 
[Data source: NSSLRL, Unpublished data] 
Table 2. Annual Number S Enteritidis by Phage Type, Ireland 2000-2010 [Top nine 
individually represented with all others combined] 
4. Outbreaks  
Salmonellae are relatively hardy microorganisms, surviving prolonged periods in frozen 
storage,42 and in manure and manure-soil mixtures;43 food at room temperature or slightly 
above, provides very favourable conditions for their multiplication. A relatively small 
inoculum (<1000 cells) is generally sufficient to produce clinical illness or colonisation.44 
Many serotypes of NTS have a particularly broad host range and may persist in the 
gastrointestinal tract of animal hosts for extended periods. These characteristics, coupled 
with the steady globalisation of the human food supply and global travel, contribute to the 
potential of Salmonella to cause both well-demarcated local and global outbreaks as well as 
periodic emergence of clonal groups which disseminate in a more diffuse manner (for 
example, as monophasic Salmonella Typhimurium has done in recent years).  
Salmonellae spread readily by means of food, from zoonotic hosts and directly from person 
to person. The progressive intensification and mechanisation of production, and 
globalisation of distribution of our food supply, has meant that outbreaks of Salmonella can 
be very extensive, and their sources, deeply embedded. In the United States during 2008-9, a 
multistate outbreak of Salmonella Typhimurium - linked to peanut butter – resulted in more 
than 700 cases of illness.45 Its final cost was expected to exceed $1Bn.46 In 2008, an outbreak 
of Salmonella Agona associated with a food production facility in Ireland led to the 
recognition of 163 associated cases of illness across Europe including two deaths; the 
implicated facility exported 800 tonnes of cooked food product across the world each week 
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(for a fuller description of this outbreak, see below).19 An important facet of Salmonella 
outbreaks (in common with many other outbreak pathogens) is that the number of cases 
detected by investigation almost invariably represents a significant underestimate of the 
true burden of illness resulting from a particular source. It is also important to note that 
although enteric salmonellosis is a self-limiting illness in most people, in most substantial 
outbreaks, a number of associated deaths (particularly among the vulnerable and elderly) is 
not uncommon. 
Outbreaks of salmonellosis are frequent events in developed countries, but show a definite 
decrease in the EU from 2,201 outbreaks in 2007 to 1,722 in 2009.47  
5. Examples where molecular microbiology was influential in hypothesis 
generation or source implication during outbreak investigations in Ireland 
The consistent and standardised application of Salmonella typing methods has enabled a 
detailed understanding of the baseline or expected incidence of specific Salmonella subtypes 
in Ireland (as is the case in almost all developed countries). This has been of critical 
importance in the detection of potential clusters based on deviation from the expected 
incidence. Close collaboration between epidemiologists and microbiologists is essential in 
forming a judgement as to which clusters are appropriate for epidemiological investigation. 
Many of the laboratory techniques are applied in reference laboratories across the developed 
world using standardised protocols. Communication of laboratory results (including results 
of genotyping studies) in standardised formats through channels such as those of the 
European Centre for Disease Prevention and Control (ECDC) and bilaterally between 
National Reference Laboratories and National Epidemiological Institutes can be vital in both 
detection and management of international outbreaks.  
A large outbreak of Salmonella Agona originating in Ireland, involving a number of 
European countries and linked to an Irish Food manufacturer in 2008 neatly illustrates the 
concept of hypothesis generation.19 In this outbreak, six cases of Salmonella Agona, each 
having the same unique PFGE profile (SAGOXB.0066) were identified within a two week 
period ( prior to this outbreak, six cases would be a typical annual total for Salmonella 
Agona isolates in Ireland). Within two weeks of the first cases having been identified, a 
review of Salmonella Trawling Questionnaires, coupled with emerging microbiological 
evidence of the outbreak strain (displaying the PFGE profile of the clinical isolates) being 
identified on the premises of an Irish food manufacturer, and in food outlets supplied by 
this same company, led investigators to hypothesise that a number of food items 
produced by the Irish Food manufacturer were the vehicles of infection via these food 
outlets. From data provided through the Salmonella Trawling Questionnaires, three 
quarters of cases reported consuming food from take-away chains and eating sandwiches 
containing chicken or pork/ham.  
Together, epidemiological and microbiological evidence augmented one another in this 
outbreak. The epidemiological evidence pointed to the commonality of exposure to 
particular types of retail food outlets (take away chains), to particular food types 
(sandwiches) and to particular ingredients (chicken ham or pork). The microbiological 
information consisted of evidence of a common serotype (Salmonella Agona), having a 
particular genotypic profile (PFGE Profile SAGOXB.0066) which was found in a large 
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number of cases across Europe, in the production plant of the Irish Food manufacturer 
and in food outlets across Europe supplied by this manufacturer (at food outlet level, the 
outbreak clonal group was eventually identified in unopened packs of food produced by 
the parent company). Taken together, this evidence was used to form a hypothesis that 
contamination due to this strain (possibly at the level of the parent company) was 
distributed by means of particular food items through a supply chain to end user food 
outlets. It was in this way that the infection was transmitted, and the outbreak 
propagated.  
In investigating the root cause of the outbreak, the investigators noted that food was cooked 
in the plant in a process that involved chicken, bacon, pork and other food types being 
placed in “continuous cook” ovens on the “low-risk” side. Cooking would take place and 
the food was then conveyed to the “high-risk” side. The investigators noted that, “a number 
of Salmonella isolates identified in the low risk area on product and in the environment between April 
and July 2008 were forwarded for definitive typing and found to be the unique pulsed field profile 
SAGOXB.0066/PT39. It appears that there was a high load of S. Agona in the low risk area and to 
such an extent that it overcame the existing control mechanisms designed to protect the high risk area 
from material in the low risk area. Such an amount of a single serovar indicated a hygiene failure 
sufficiently to propagate such an outbreak.” 
When remediation measures were put in place in the affected production plant, the 
outbreak was controlled.  
Without PFGE methods it would have been much more difficult to separate out the 
outbreak Salmonella Agona isolates from non travel-associated endemic isolates across 
multiple countries. Use of PFGE was instrumental in focussing the investigation towards the 
likelihood that the outbreak was caused by an internationally distributed commodity, in this 
case, a food product. PFGE was also used to distinguish between at least one other 
contemporaneous background Irish S. Agona case and the outbreak strain, thus enabling 
this case to be eliminated from the descriptive and analytical epidemiological investigations. 
Ensuring that unrelated cases are not included as outbreak cases in analytical studies is 
particularly important as their exclusion reduces the risk of misclassification (a form of bias), 
which could alter estimation of the effect size.  
The authors of the Outbreak Report say as much when they note that “The detection of the 
source identified would not have been possible without the use of molecular typing 
techniques and the sharing of data and co-operation between numerous agencies.” 48  
Similarly, a cluster of seven cases diagnosed with S. Heidelberg (an uncommon serotype in 
Ireland) was identified in 2011.49 In investigating this outbreak, the identification of isolates 
in reference laboratories in Europe and North America with PFGE profiles indistinguishable 
from those of the Irish S. Heidelberg isolates permitted the recognition of cases which were 
investigated for possible epidemiological links to the Irish cases. Travel to Tanzania was 
identified as a common risk factor among cases. Accumulated evidence over a number of 
years of an association between this serotype and East Africa (among other regions) 
provided useful circumstantial evidence supporting the hypothesis that the infection was 
associated with the travel destination. PFGE was important in focussing this investigation 
towards specific exposures, as the Irish cases had travelled as a group and had shared many 
exposures throughout their trip making it difficult to establish which was the likely source 
of infection. In the absence of formal standardisation of molecular typing methods, it would 
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not have been possible to establish the potential links between these international cases, 
which might otherwise have been considered to be unlinked. 
Unusually in 2010, DT8 was the most common S. Typhimurium definitive type detected in 
Ireland. This was due to the occurrence of an outbreak which was associated with exposure 
to duck eggs.50 Prior to 2009, there had only been three cases of this definitive type detected 
over an eight-year period. The detection initially of a cluster of three S. Typhimurium DT8 
isolates by the reference laboratory within a one-month period in the latter half of 2009, 
followed by a further cluster of four cases five months later led to the recognition of a 
temporally diffuse outbreak of 35 cases which occurred over an 18 month period. In this 
outbreak, hypothesis generation was based primarily on the classical descriptive 
epidemiological method of administering a trawling questionnaire; however, particularly 
strong evidence pointing towards the association between the human cases and duck egg 
exposure was provided through comparison of molecular profiles of S. Typhimurium 
isolates from implicated duck egg farms with isolates from human cases using both MLVA 
and PFGE. The work of national veterinary reference laboratory and effective liaison 
between human and veterinary reference laboratory services was also indispensable in 
defining the source of this outbreak.  
This evidence was key in enabling control measures to be introduced, including the signing 
into Irish law of new legislation (S.I. No. 565 of 2010), the ‘Diseases of Animals Act 1966 
(Control of Salmonella in Ducks) Order 2010’, which now sets down a legal basis for the 
control of salmonellosis in egg-laying duck flocks in Ireland. 
Unfortunately, the identification of clusters by microbiological methods does not 
guarantee a successful outcome to the subsequent epidemiological investigation. On a 
number of occasions, outbreak control teams have been established to investigate clusters 
identified in this manner, but for which no definitive epidemiological link could be 
established between cases and no source of infection was identified. For example, a 
temporally-defined but geographically diffuse cluster of S. Typhimurium DT193 was 
investigated in 2009. MLVA was used to define those DT193 isolates occurring that year 
which were included in the investigation. And in 2009, an outbreak control team was 
established to investigate a rise in the incidence of S Enteritidis PT14b. In neither instance 
could a definitive epidemiological link be established between the cases and no sources of 
infection were identified. 
Known associations between particular reservoirs and Salmonella serotypes has been 
exploited in source attribution studies.51 This kind of information is also useful in outbreak 
investigation as it can give an early pointer of likely vehicles for particular strains for 
hypothesis generation. 
6. Emerging factors  
In Ireland, it has become apparent in recent years that overseas travel plays an important 
role in Salmonella epidemiology. It is now estimated that up to half of all notified cases may 
be travel associated (Table 3). This is broadly similar to the proportions in Finland, Sweden 
and Norway, all of whom report that more than 70% of their salmonellosis cases are travel-
associated and is in contrast to the majority of countries in central and southern Europe who 
report this to be a largely indigenous disease.4  
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 Number of cases 
% of total number 
of cases 
% of cases with 
known travel 
history 
Indigenous 351 31% 51% 
Travel-associated 342 30% 49% 
Unknown/not 
specified 
445 39% - 
Total 1138 100% 100% 
[Data source: CIDR] 
Table 3. Number and percentage Salmonella notifications by Travel history, Ireland 2008-2010 
Combining epidemiological information on case travel histories with microbiological 
information enabled confirmation that S. Enteritidis is uncommon among indigenous 
salmonellosis cases in Ireland, with a high proportion being associated with overseas 
exposure,29 while S. Typhimurium is clearly the dominant serotype among indigenous 
cases. This is supported by outbreak surveillance data (Table 4). These combined data have 
also been exploited in studies such as a recent EFSA source attribution study which 
suggested that after the risk factor ‘travel’, pigs may be the most important contributor to 











S Enteritidis 13 13 26 
S Typhimurium 3 37 40 
Other Salmonella serotypes 5 24 29 
Salmonella serotype not reported 4 10 14 
Total 25 84 109 
[Data source: CIDR] 
Table 4. Number Salmonella outbreaks (family and general) by serotype and travel 
association, Ireland 2004-2010 
7. Conclusion  
Salmonellosis continues to be an important global cause of infectious intestinal disease and 
in developed countries maintains its dominant position as one of the top three commonest 
causes of bacterial gastroenteritis. Enteric salmonellae are potent outbreak organisms and 
linking of cases that are part of the same outbreak has been facilitated by the recent 
increased application of molecular methods of characterisation that allow increasingly 
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reliable differentiation and discrimination between and within serotypes. The progressive 
refinement of discriminatory methods permits the ready inclusion (and exclusion) of isolates 
within outbreaks in such a way that reduces wasteful investigation of unrelated isolates of 
the same serotype, while identifying more accurately the true extent of outbreaks. This has 
been assisted by the increasingly rapid turnaround time for identification of such isolates. 
Long lead-in time of such methods in the past made them more suited to research purposes 
but the rapidity with which microbiologists can provide results to epidemiologists makes 
this a real-time method that facilitates investigation and allows more rapid implementation 
of control measures. However, the most fundamental requirement in the application of 
laboratory characterisation of isolates to the protection of public health is not the 
sophistication of the laboratory methods, but open, effective and timely communication 
between those delivering the laboratory services and those in the public health and food 
safety domains charged with surveillance and intervention. 
8. References 
 
[1] Tauxe R. Centers for Disease Control and Prevention, National Notifiable Diseases 
Surveillance Data. 2004. 
[2] Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ, Jones TF, Fazil A, 
Hoekstra RM; International Collaboration on Enteric Disease 'Burden of Illness' 
Studies. The global burden of non-typhoidal Salmonella gastroenteritis. Clin Infect 
Dis. 2010 Mar 15;50(6):882-9.) 
[3] Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, et al. 
Foodborne illness acquired in the United States—major pathogens. Emerg Infect 
Dis. 2011 Jan;17(1):7-15. 
[4] European Food Safety Authority. The European Union Summary Report on Trends and 
Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2009. EFSA Journal 
2011; 9(3):2090. [378pp.] doi:10.2903/j.efsa.2011.2090. Available online: 
www.efsa.europa.eu/efsajournal. 
[5] The European Centre for Disease Prevention and Control. Annual Epidemiological 
Report on Communicable Diseases in Europe, 2010. Stockholm: 2010. 
[6] Centers for Disease Control and Prevention (CDC). Vital signs: incidence and trends of 
infection with pathogens transmitted commonly through food--foodborne 
diseases active surveillance network, 10 U.S. sites, 1996-2010. MMWR Morb 
Mortal Wkly Rep. 2011 Jun 10;60(22):749-55. 
[7] Tam CT, Rodrigues L, Viviani L, et al. 2011. Longitudinal study of infectious intestinal 
disease in the UK (IID2 study): incidence in the community and presenting to 
general practice. Gut doi:10.1136/gut.2011.238386  
[8] De Jong B, Ekdahl K. The comparative burden of salmonellosis in the European Union 
member states, associated and candidate countries. BMC Public Health. 2006 Jan 
10;6:4.K. 
[9] Elson R; Outbreak Control Team. UK Health Protection Agency view on food alert 
announcing the recall of a number of confectionery products. Euro Surveill. 2006 
Jun 29;11(6):E060629.2. 
 
Elucidating the Epidemiology of Human Salmonellosis:  




[10] Werber D, Dreesman J, Feil F, van Treeck U, Fell G, Ethelberg S, Hauri AM, 
Roggentin P, Prager R, Fisher IS, Behnke SC, Bartelt E, Weise E, Ellis A, Siitonen 
A, Andersson Y, Tschäpe H, Kramer MH, Ammon A. International outbreak of 
Salmonella Oranienburg due to German chocolate. BMC Infect Dis. 2005 Feb 
3;5:7. 
[11] Craven PC, Mackel DC, Baine WB, Barker WH, Gangarosa EJ. International outbreak 
of Salmonella Eastbourne infection traced to contaminated chocolate. Lancet. 
1975 Apr 5;1(7910):788-92. 
[12] Gillespie IA, Elson R. Successful reduction of human Salmonella Enteritidis infection 
in England and Wales. Euro Surveill. 2005;10(46):pii=2834. 
[13] Threlfall EJ, Ward LR, Hampton MD, Ridley AM, Rowe B, Roberts D, Gilbert RJ, Van 
Someren P, Wall PG, Grimont P. Molecular fingerprinting defines a strain of 
Salmonella enterica serotype Anatum responsible for an international outbreak 
associated with formula-dried milk. Epidemiol Infect. 1998 Oct;121(2):289-93. 
[14] Pezzoli L, Elson R, Little CL, Yip H, Fisher I, Yishai R, Anis E, Valinsky L, Biggerstaff 
M, Patel N, Mather H, Brown DJ, Coia JE, van Pelt W, Nielsen EM, Ethelberg S, 
de Pinna E, Hampton MD, Peters T, Threlfall. Packed with Salmonella--
investigation of an international outbreak of Salmonella Senftenberg infection 
linked to contamination of prepacked basil in 2007. J.Foodborne Pathog Dis. 2008 
Oct;5(5):661-8. 
[15] Van Duynhoven YT, Isken LD, Borgen K, Besselse M, Soethoudt K, Haitsma O, 
Mulder B, Notermans DW, De Jonge R, Kock P, Van Pelt W, Stenvers O, Van 
Steenbergen J; Outbreak Investigation Team. A prolonged outbreak of Salmonella 
Typhimurium infection related to an uncommon vehicle: hard cheese made from 
raw milk. Epidemiol Infect. 2009 Nov;137(11):1548-57. 
[16] Bruun T, Sørensen G, Forshell LP, Jensen T, Nygard K, Kapperud G, Lindstedt BA, 
Berglund T, Wingstrand A, Petersen RF, Müller L, Kjelsø C, Ivarsson S, Hjertqvist 
M, Löfdahl S, Ethelberg S. An outbreak of Salmonella Typhimurium infections in 
Denmark, Norway and Sweden, 2008. Euro Surveill. 2009 Mar 12;14(10). 
[17] Nygård K, Lassen J, Vold L, Andersson Y, Fisher I, Löfdahl S, Threlfall J, Luzzi I, 
Peters T, Hampton M, Torpdahl M, Kapperud G, Aavitsland P. Outbreak of 
Salmonella Thompson infections linked to imported rucola lettuce. Foodborne 
Pathog Dis. 2008 Apr;5(2):165-73.  
[18] Puohiniemi R, Heiskanen T, Siitonen A. Molecular epidemiology of two international 
sprout-borne Salmonella outbreaks. J Clin Microbiol. 1997 Oct;35(10):2487-91. 
[19] Nicolay N, Thornton L, Cotter S, Garvey P, Bannon O, McKeown P, Cormican M et al. 
Salmonella enterica serovar Agona European outbreak associated with a food 
company. Epidemiol Infect. 2010 18:1-9. 
[20] Nylen G, Fielder HM, Palmer SR. An international outbreak of Salmonella enteritidis 
associated with lasagne; lessons on the need for cross-national co-operation in 
investigating food-borne outbreaks. Epidemiol Infect. 1999 Aug;123(1):31-5. 
[21] Anon. An international outbreak of human salmonellosis associated with animal-
derived pet treats--Canada and Washington state, 2005. Can Commun Dis Rep. 
2006 Jul 1;32(13):150-5. 
 
 




[22] Unicomb LE, Simmons G, Merritt T, Gregory J, Nicol C, Jelfs P, Kirk M, Tan A, 
Thomson R, Adamopoulos J, Little CL, Currie A, Dalton CB. Sesame seed 
products contaminated with Salmonella: three outbreaks associated with tahini. 
Epidemiol Infect. 2005 Dec;133(6):1065-72. 
[23] Isaacs S, Aramini J, Ciebin B, Farrar JA, Ahmed R, Middleton D, Chandran AU, 
Harris LJ, Howes M, Chan E, Pichette AS, Campbell K, Gupta A, Lior LY, Pearce 
M, Clark C, Rodgers F, Jamieson F, Brophy I, Ellis A; Salmonella Enteritidis PT30 
Outbreak Investigation Working Group. An international outbreak of 
salmonellosis associated with raw almonds contaminated with a rare phage type 
of Salmonella enteritidis. J Food Prot. 2005 Jan;68(1):191-8. 
[24] Kirk MD, Little CL, Lem M, Fyfe M, Genobile D, Tan A, Threlfall J, Paccagnella A, 
Lightfoot D, Lyi H, McIntyre L, Ward L, Brown DJ, Surnam S, Fisher IS. An 
outbreak due to peanuts in their shell caused by Salmonella enterica serotypes 
Stanley and Newport--sharing molecular information to solve international 
outbreaks. Epidemiol Infect. 2004 Aug;132(4):571-7.  
[25] Sheth AN, Hoekstra M, Patel N, Ewald G, Lord C, Clarke C, Villamil E, Niksich K, 
Bopp C, Nguyen TA, Zink D, Lynch M. A national outbreak of salmonella 
serotype tennessee infections from contaminated peanut butter: a new food 
vehicle for salmonellosis in the United States. Clin Infect Dis. 2011 Aug;53(4):356-
62. 
[26] Ward LR, Maguire C, Hampton MD, de Pinna E, Smith HR, Little CL, Gillespie IA, 
O'Brien SJ, Mitchell RT, Sharp C, Swann RA, Doyle O, Threlfall EJ. Collaborative 
investigation of an outbreak of Salmonella enterica serotype Newport in England 
and Wales in 2001 associated with ready-to-eat salad vegetables. .Commun Dis 
Public Health. 2002 Dec;5(4):301-4. 
[27] European Food Safety Authority. The Community Summary Report on trends and 
sources of zoonoses, zoonotic agents and food-borne outbreaks in the European 
Union in 2008. European Food Safety Authority (EFSA), Parma: 2010.  
[28] Newell DG, Koopmans M, Verhoef L, Duizer E, Aidara-Kane A, Sprong H, Opsteegh 
M, Langelaar M, Threfall J, Scheutz F, van der Giessen J, Kruse H. Food-borne 
diseases - the challenges of 20 years ago still persist while new ones continue to 
emerge. Int J Food Microbiol. 2010 May 30;139 Suppl 1:S3-15. 
[29] Garvey P, Scally M, McKeown P, de Lappe N, Doran G, Ward J, Cormican M. 
Indigenous salmonellosis low in Ireland. Epi-Insight. 2010 March; 11(3). Available 
at http://ndsc.newsweaver.ie/epiinsight/hkybj5cdjbb1l6t6mifk6p. Accessed 
14/9/2011. 
[30] Hendriksen R. Global epidemiology of non-typhoidal Salmonella infections in humans. PhD 
Thesis. National Food Institute, Copenhagen. Print 
[31] SMI. Swedish national surveillance data, , available at  
http://www.smittskyddsinstitutet.se/in-
english/statistics/salmonellosis/?t=c#statistics-nav, accessed 22/8/2011) 
[32] St Louis ME, Morse DL, Potter ME, DeMelfi TM, Guzewich JJ, Tauxe RV, Blake PA. 
The emergence of grade A eggs as a major source of Salmonella enteritidis 
 
Elucidating the Epidemiology of Human Salmonellosis:  




infections. New implications for the control of salmonellosis. JAMA. 1988 Apr 
8;259(14):2103-7. 
[33] Bäumler AJ, Hargis BM, Tsolis RM. Tracing the origins of Salmonella outbreaks. 
Science. 2000 Jan 7;287(5450):50-2. 
[34] Rodrigue DC, Tauxe RV, Rowe B. International increase in Salmonella enteritidis: a 
new pandemic? Epidemiol Infect. 1990 Aug;105(1):21-7. 
[35] HPSC’s national Salmonella Trawling Questionnaire. Available at  
http://www.hpsc.ie/hpsc/A-
Z/Gastroenteric/Salmonellosis/SurveillanceForms. Accessed on 25/8/2011.  
[36] Lan R, Reeves PR, Octavia S. Population structure, origins and evolution of major 
Salmonella enterica clones. Infect Genet Evol. 2009; 9(5):996-1005.  
[37] Gerner-Smidt P, Hise K, Kincaid J, Hunter S, Rolando S, Hyytiä-Trees E, Ribot EM, 
Swaminathan B; Pulsenet Taskforce. PulseNet USA: a five-year update. Foodborne 
Pathog Dis. 2006;3(1):9-19. Review.  
[38] Petersen RF, Litrup E, Larsson JT, Torpdahl M, Sørensen G, Müller L, Nielsen EM. 
Molecular Characterisation of Salmonella Typhimurium Highly Successful 
Outbreak Strains. Foodborne Pathog Dis. 2011 Mar 7. [Epub ahead-of-print]. 
[39] Gregg M. Field Epidemiology. Oxford University Press, Oxford: 1996. 
[40] Hadjinicolaou AV, Demetriou VL, Emmanuel MA, Kakoyiannis CK, Kostrikis LG. 
Molecular beacon-based real-time PCR detection of primary isolates of Salmonella 
Typhimurium and Salmonella Enteritidis in environmental and clinical samples. 
BMC Microbiol. 2009 19;9:97. 
[41] The Health Protection Surveillance Centre. Salmonella In the Annual Report of the 
Health Protection Surveillance Centre, 2008. HPSC, Dublin: 2009. 
[42] Dominguez SA, Schaffner DW. Survival of salmonella in processed chicken products 
during frozen storage. J Food Prot. 2009 Oct;72(10):2088-92. 
[43] You Y, Rankin SC, Aceto HW, Benson CE, Toth JD, Dou Z. Survival of Salmonella 
enterica serovar Newport in manure and manure-amended soils. Appl Environ 
Microbiol. 2006 Sep;72(9):5777-83. 
[44] Blaser MJ, Newman LS. A review of human salmonellosis: I. Infective dose. Rev Infect 
Dis. 1982 Nov-Dec;4(6):1096-106. 
[45] Centers for Disease Control and Prevention. Multistate outbreak of Salmonella 
infections associated with peanut butter and peanut butter-containing products--
United States, 2008-2009. MMWR Morb Mortal Wkly Rep. 2009 Feb 6;58(4):85-90.  
[46] Peanut recall having big impact on small firms. Reuters. March 11, 2009. Available at 
http://www.reuters.com/article/2009/03/11/us-salmonella-peanuts-
idUSTRE52A4AT20090311. Accessed 22/9/2011. 
[47] European Food Safety Authority. The Community Summary Report on Trends and 
Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in the 
European Union in 2008. EFSA Journal; 2010 8(1):1496.  
[48] Report of an International Outbreak Investigation into a Multi–country Outbreak of 
Salmonella Agona, Europe, 2008. Available at  
http://www.hpsc.ie/hpsc/A-Z/Gastroenteric/Salmonellosis/Outbreaks/ 
File,12549,en.pdf. Accessed 13/9/2011. 
 
 




[49] Rebolledo J et al. Outbreak of Salmonella Heidelberg Associated with an Aircraft 
Flight from Tanzania, July 2011. In preparation. 
[50] Garvey P, McKeown P. Two new cases linked with nationwide 'duck egg' outbreak of 
Salmonella Typhimurium DT8. Epi-Insight. 2011 April. 12(4). Available at  
http://ndsc.newsweaver.ie/epiinsight/3zg0ibihqqw87nh5ab6w5b. Accessed 
17/9/2011. 
[51] European Food Safety Authority. Estimation of the relative contribution of different food 
and animal sources to human Salmonella infections in the European Union. July 2011. 
EFSA, Parma: 2011. Available at  
http://www.efsa.europa.eu/en/supporting/pub/184e.htm. Accessed 14/10/2011. 
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
